Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer’s disease ; volume:20 ; number:1 ; day:13 ; month:12 ; year:2023 ; pages:1-16 ; date:12.2023
Journal of neuroinflammation ; 20, Heft 1 (13.12.2023), 1-16, 12.2023
- Urheber
-
Nordengen, Kaja
Kirsebom, Bjørn-Eivind
Richter, Grit
Pålhaugen, Lene
Gísladóttir, Berglind
Siafarikas, Nikias
Nakling, Arne
Rongve, Arvid
Bråthen, Geir
Grøntvedt, Gøril Rolfseng
Gonzalez, Fernando
Waterloo, Knut
Sharma, Kulbhushan
Karikari, Thomas
Vromen, Eleonora M.
Tijms, Betty M.
Visser, Pieter J.
Selnes, Per
Kramberger, Milicia G.
Winblad, Bengt
Blennow, Kaj
Fladby, Tormod
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12974-023-02973-w
- URN
-
urn:nbn:de:101:1-2024022810534047069025
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nordengen, Kaja
- Kirsebom, Bjørn-Eivind
- Richter, Grit
- Pålhaugen, Lene
- Gísladóttir, Berglind
- Siafarikas, Nikias
- Nakling, Arne
- Rongve, Arvid
- Bråthen, Geir
- Grøntvedt, Gøril Rolfseng
- Gonzalez, Fernando
- Waterloo, Knut
- Sharma, Kulbhushan
- Karikari, Thomas
- Vromen, Eleonora M.
- Tijms, Betty M.
- Visser, Pieter J.
- Selnes, Per
- Kramberger, Milicia G.
- Winblad, Bengt
- Blennow, Kaj
- Fladby, Tormod
- SpringerLink (Online service)
Ähnliche Objekte (12)
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium